Sanofi
$42.48
+0.24 · +0.58% today
Market open · updated 12:45:29 PM ET
- High
- $42.38 4:20 AM
- Low
- $42.17 4:50 AM
Against the S&P 500 Price change through Oct 28, 2026
SNY−12.84%
S&P 500+13.26%
SNY−17.27%
S&P 500+12.41%
SNY−2.06%
S&P 500+88.06%
SNY−15.76%
S&P 500+68.51%
Key numbers
- Previous close
- $42.24
- Open
- $42.34
- Day's range
- $42.17 – $42.59
- 52-week range
- $39.07 – $52.68
- Volume
- 1.4 million
- Average volume
- 3.2 million
- Market value
- $101.8 billion
- Price to earnings
- 23.1last 12 months
- Earnings per share
- $1.65last 12 months
- Beta
- 0.30moves less than the market
- Dividend
- $4.17 a year · 11.04%
- 50-day average
- $42.28
- 200-day average
- $44.36
Friday, Oct 30, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Sanofi sells to and competes with From our value chain
Sanofi in the news
- HeadlineRegeneron's Billion-Dollar Catalyst Flying Under Wall Street's Radar Ahead of Oct. 30 Earnings24/7 Wall Street · October 26, 2026 at 9:39 AM ET
- HeadlineSanofi: An Alluring And Balanced Mix Of Yield And GrowthSeeking Alpha · October 26, 2026 at 9:30 AM ET
- Company earningsThermo Fisher Scientific tops Q3 estimates, but shares slide premarketWiseView Research desk · October 21, 2026
- HeadlineSanofi: Why The Market Seems To Be Overpricing Pipeline RiskSeeking Alpha · October 20, 2026 at 3:26 PM ET
- HeadlineEnable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery SystemGlobeNewsWire · October 19, 2026 at 8:04 AM ET
- HeadlinePress Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in GermanyGlobeNewsWire · October 19, 2026 at 6:30 AM ET
- HeadlineRecursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their CollaborationGlobeNewsWire · October 15, 2026 at 8:45 AM ET
- CongressLisa McClain sold $1,001 - $15,000 of SNYHouse filing · disclosed Oct 22, 2025
Earnings
Next report: Friday, Oct 30, 2026, before the open.
Congress trades in SNY
1 purchase and 2 sales in the latest 3 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Lisa McClainHouse · R-Michigan | Sale | $1,001 - $15,000 | Sep 11, 2025 | Oct 22, 2025 |
| Lisa McClainHouse · R-Michigan | Sale | $1,001 - $15,000 | Jul 22, 2025 | Aug 13, 2025 |
| Lisa McClainHouse · R-Michigan | Purchase | $1,001 - $15,000 | Jun 17, 2025 | Aug 13, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Sanofi
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 76,493
- Headquarters
- Paris, France
- Website
- sanofi.com
- Listed
- Jul 1, 2002
More drug manufacturers - general stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.